搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Clostridium difficile Phosphoglucosamine mutase (glmM) CSB-YP623251CAAQ
CSB-EP623251CAAQ
CSB-BP623251CAAQ
CSB-MP623251CAAQ
CSB-EP623251CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Redox-sensing transcriptional repressor rex (rex) CSB-YP623252CAAQ
CSB-EP623252CAAQ
CSB-BP623252CAAQ
CSB-MP623252CAAQ
CSB-EP623252CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Carbon storage regulator homolog (csrA) CSB-YP623253CAAQ
CSB-EP623253CAAQ
CSB-BP623253CAAQ
CSB-MP623253CAAQ
CSB-EP623253CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP623254HAAE
CSB-EP623254HAAE
CSB-BP623254HAAE
CSB-MP623254HAAE
CSB-EP623254HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi DNA repair and recombination protein radA (radA) CSB-YP623255HAAE
CSB-EP623255HAAE
CSB-BP623255HAAE
CSB-MP623255HAAE
CSB-EP623255HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L31e (rpl31e) CSB-YP623256HAAE
CSB-EP623256HAAE
CSB-BP623256HAAE
CSB-MP623256HAAE
CSB-EP623256HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 30S ribosomal protein S12P (rps12p) CSB-YP623257HAAE
CSB-EP623257HAAE
CSB-BP623257HAAE
CSB-MP623257HAAE
CSB-EP623257HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Chorismate synthase (aroC) CSB-YP623258HAAE
CSB-EP623258HAAE
CSB-BP623258HAAE
CSB-MP623258HAAE
CSB-EP623258HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi V-type ATP synthase subunit E (atpE) CSB-YP623259HAAE
CSB-EP623259HAAE
CSB-BP623259HAAE
CSB-MP623259HAAE
CSB-EP623259HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi V-type ATP synthase alpha chain (atpA), partial CSB-YP623260HAAE
CSB-EP623260HAAE
CSB-BP623260HAAE
CSB-MP623260HAAE
CSB-EP623260HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Deoxyribose-phosphate aldolase (deoC) CSB-YP623261HAAE
CSB-EP623261HAAE
CSB-BP623261HAAE
CSB-MP623261HAAE
CSB-EP623261HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Probable molybdenum cofactor biosynthesis protein A (moaA) CSB-YP623262HAAE
CSB-EP623262HAAE
CSB-BP623262HAAE
CSB-MP623262HAAE
CSB-EP623262HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L11P (rpl11p) CSB-YP623263HAAE
CSB-EP623263HAAE
CSB-BP623263HAAE
CSB-MP623263HAAE
CSB-EP623263HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L7Ae (rpl7Ae) CSB-YP623264HAAE
CSB-EP623264HAAE
CSB-BP623264HAAE
CSB-MP623264HAAE
CSB-EP623264HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Serine hydroxymethyltransferase (glyA) CSB-YP623265HAAE
CSB-EP623265HAAE
CSB-BP623265HAAE
CSB-MP623265HAAE
CSB-EP623265HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Probable DNA primase small subunit (priA) CSB-YP623266HAAE
CSB-EP623266HAAE
CSB-BP623266HAAE
CSB-MP623266HAAE
CSB-EP623266HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi DNA ligase 2 (lig2), partial CSB-YP623267HAAE
CSB-EP623267HAAE
CSB-BP623267HAAE
CSB-MP623267HAAE
CSB-EP623267HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi DNA gyrase subunit A (gyrA), partial CSB-YP623268HAAE
CSB-EP623268HAAE
CSB-BP623268HAAE
CSB-MP623268HAAE
CSB-EP623268HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Carboxylate-amine ligase HQ2566A (HQ2566A) CSB-YP623269HAAE
CSB-EP623269HAAE
CSB-BP623269HAAE
CSB-MP623269HAAE
CSB-EP623269HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Putative nickel-responsive regulator (HQ2221A) CSB-YP623270HAAE
CSB-EP623270HAAE
CSB-BP623270HAAE
CSB-MP623270HAAE
CSB-EP623270HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>